PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN- A PROSPECTIVE ANALYSIS
May 1, 2009, 00:00
10.1016/S1098-3015(10)73081-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)73081-3/fulltext
Title :
PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN- A PROSPECTIVE ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73081-3&doi=10.1016/S1098-3015(10)73081-3
First page :
Section Title :
Open access? :
No
Section Order :
626